Brain tumour clinical trial title
IPI-GLIO immunotherapy trial
Brain tumour type
Glioblastoma,
Website
www.clinicaltrialsregister.eu/ctr-search/trial/2018-000095-15/GB#E
Description:
A Phase II, Open Label, Randomised Study of Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma.
Date added:
19th March 2019
Open/Closed:
Open
Trial ends:
Provider
Oncology Clinical Trials Office, University of Oxford
Contact details